You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 253 No. 11, March 15, 1985 TABLE OF CONTENTS
  JAMA
  •  Online Features
  COUNCIL REPORT
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (9)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Guidelines for Handling Parenteral Antineoplastics

Council on Scientific Affairs

JAMA. 1985;253(11):1590-1592.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

BACKGROUND

The growing professional concern over the potential carcinogenic hazards associated with the handling of antineoplastic agents has resulted in the publication of studies concerned with the detection of metagenic effects in hospital staff involved with cancer chemotherapy, as well as publication of numerous guidelines to minimize exposure to antineoplastic agents. Although the actual hazards associated with the handling of parenteral antineoplastic drugs have not been established, the issue of ensuring the safety of all health care personnel is becoming a broader public concern.1

The objectives of this report are to (1) review the scientific data regarding the risks to physicians and other health care personnel in handling and administering parenteral antineoplastic drugs; (2) study the guidelines recommended by the National Institutes of Health (NIH) and other sources for the safe handling of parenteral antineoplastic drugs; and (3) determine whether the currently available guidelines are adequate to ensure safe . . . [Full Text PDF of this Article]


Author Affiliations

From the Council on Scientific Affairs, Division of Drugs and Technology, American Medical Association, Chicago.


Footnotes

Report D of the Council on Scientific Affairs, adopted by the House of Delegates of the American Medical Association at the Interim Meeting, December 1984.

This report is not intended to be construed or to serve as a standard of medical care. Standards of medical care are determined on the basis of all of the facts and circumstances involved in an individual case and are subject to change as scientific knowledge and technology advance and patterns of practice evolve. This report reflects the views of scientific experts and reports in the scientific literature as of December 1984.

Reprint requests to Council on Scientific Affairs, Division of Drugs and Technology, American Medical Association, 535 N Dearborn St, Chicago, IL 60610 (John C. Ballin, PhD).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1985 American Medical Association. All Rights Reserved.